What Happened: The New York State Trooper Case

A New York State Trooper was terminated from his position after testing positive for THC on two separate drug tests. He has filed a lawsuit seeking reinstatement, and the case is currently pending — no court has ruled on whether the termination was lawful. The core dispute centers on whether off-duty cannabis use can legally justify termination under New York's current cannabis framework.

The New York State Police operates under different rules than private employers — as a law enforcement agency with federal nexus and public-safety obligations, it maintains its own drug testing standards. But the legal and policy questions the case raises are directly relevant to private employers across New York, particularly as the state's cannabis regulations have continued to evolve since recreational legalization took effect.

New York Cannabis Law and the Impairment Standard

New York legalized adult-use cannabis in 2021 under the Marijuana Regulation and Taxation Act. Under that law, most private employers in New York cannot discipline or terminate an employee solely because they use cannabis off-duty and outside the workplace. The state's Office of Cannabis Management, which maintains the regulatory framework at cannabis.ny.gov, has made clear that off-duty cannabis use is treated similarly to off-duty alcohol use — employers do not have blanket authority to penalize it.

What employers can do is take action when an employee manifests specific articulable symptoms of impairment while at work — observable signs that the person cannot perform their job safely and effectively. The challenge this creates is practical: a positive urine THC test does not tell you when the employee last used cannabis. THC metabolites remain detectable in urine for days to weeks after the effects of cannabis have completely worn off. A positive test result and on-the-job impairment are two different things, and New York law treats them differently.

What This Means for New York Employers Heading Into 2027

The state trooper case is a vivid illustration of the policy gap many New York employers are navigating: they have legitimate safety interests, they may have written drug-free workplace policies that predate recreational legalization, and they are now operating in a legal environment where a positive THC test is not the clean answer it once was.

Private employers in New York have two practical paths forward for their drug testing programs:

1. Retain THC in the panel with an updated impairment-based policy. Employers in safety-sensitive industries — construction, transportation, heavy manufacturing — may choose to keep THC in their testing panel while shifting their policy language from "positive test = termination" to a documented impairment-plus-test standard. This requires supervisor training on observable impairment indicators and contemporaneous documentation of behavioral observations before a test is ordered.

2. Remove THC from the panel entirely. For employers whose primary concern is drugs that directly impair performance — cocaine, methamphetamine, opiates, benzodiazepines — removing THC from the screening panel sidesteps the off-duty use liability entirely. A non-THC drug test still screens for the substances most associated with on-the-job impairment risk, without creating a paper trail of THC positives that may be legally difficult to act on. For a full breakdown of how New York employers are using non-THC panel configurations, see our guide to staying compliant with non-THC drug test panels in New York.

The Takeaway for Employers Outside New York

The New York state trooper case is being watched beyond New York because the underlying legal tension — positive THC test versus proof of impairment — is playing out in states across the country as cannabis legalization continues to expand. Employers in states without strong off-duty use protections today may face similar frameworks within the next legislative cycle.

The clearest path for any employer is a written drug-free workplace policy that distinguishes between a positive test result and documented on-the-job impairment, trains supervisors to recognize and document observable impairment indicators, and selects a drug test panel that matches the employer's actual legal risk profile — not just whatever configuration has always been ordered.